Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Central nervous system tissue is the major tissue type composing the brain and spinal cord, containing billions of neurons and glial cells organized into distinct regions and layers, with complex connectivity and biochemical properties. It is mapped by anatomical features such as **gray matter** (rich in neuronal cell bodies and unmyelinated axons) and **white matter** (rich in myelinated axons), with further molecular segmentation possible via transcriptomics and spatial gene expression. CNS tissue is not a molecular therapeutic target but rather the context for many targets (receptors, ion channels, enzymes, etc.), and is a site of various pathologies including tumors, neurodegeneration, trauma, and developmental disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Central nervous system tissue (CNS tissue).